The β3‐AR agonist BRL37344 ameliorates the main symptoms of X‐linked nephrogenic diabetes insipidus in the mouse model of the disease
Article in Journal of Cellular and Molecular Medicine (April 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Journal of Cellular and Molecular Medicine (April 2024)
Article in Frontiers in Physiology (February 2024)
Article in International Journal of Molecular Sciences (January 2023)